Haemonetics Corp. (NYSE: HAE) reported Q3 EPS of $0.86, $0.06 better than the analyst estimate of $0.80. Revenue for the quarter came in at $191.2 million versus the consensus estimate of $186.21 million.

Affirms outlook.

For earnings history and earnings-related data on Haemonetics Corp. (HAE) click here.

Earnings Guidance